merck glp 1 agonist 20 Companies in Glucagon-Like Peptide-1 Agonists Market Size How GLP-1 Receptor Agonists Evolved

One critical warning

protects heart health

The combination yields greater weight loss than either agent alone, with mean reductions in body weight of approximately 20.4% over 68 weeks in non-diabetic adults and 13.7% in those with type 2 diabetesfar exceeding placebo and monotherapy arms

Patel K, Harrison SA, Elkhashab M et al (2020) Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

Speak with your healthcare provider Always consult with a doctor or pharmacist for personalized medical advice and guidance

( 10.1056/NEJMoa2302392) [DOI] [PubMed] [Google Scholar] Wilson JM Nikooienejad A Robins DA Roell WC Riesmeyer JS Haupt A Duffin KL Taskinen MR & Ruotolo G